Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 729, Issue 1-2, 2012, Pages 24-34

  Kumar, Anil ^a   Pant, Mohan Chand ^b   Singh, Hirdya Shanker ^c   Khandelwal, Shashi ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c CH CHARAN SINGH UNIVERSITY   (India)

Author keywords

Head and neck cancer; Polymorphism; XPD; XRCC1

Indexed keywords

ARGININE; GENOMIC DNA; GLUTAMINE; HISTIDINE; LYSINE; TRYPTOPHAN; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; AMINO ACID SUBSTITUTION; ARTICLE; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA REPAIR; EXCISION REPAIR; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HEAD AND NECK CARCINOMA; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; INDIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MUTATION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; WILD TYPE; XPD GENE; XRCC1 GENE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA REPAIR; DNA-BINDING PROTEINS; EPISTASIS, GENETIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEAD AND NECK NEOPLASMS; HUMANS; INDIA; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 83555162511     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.09.001     Document Type: Article

References (64)

1. Hunter K.D., Parkinson E.K., Harrison P.R. Profiling early head and neck cancer. Nat. Rev. Cancer 2005, 5:127-135.
2. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160:1-40.
3. Gupta P.C., Ray C.S. Smokeless tobacco and health in India and south Asia. Respirology 2003, 8:419-431.
4. Pfeifer G.P., Denissenko M.F., Olivier M., Tretyakova N., Hecht S.S., Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002, 21:7435-7451.
5. Zhong Y., Carmella S.G., Upadhyaya P., Hochalter J.B., Rauch D., Oliver A., Jensen J., Hatsukami D., Wang J., Zimmerman C., Hecht S.S. Immediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxides. Chem. Res. Toxicol. 2011, 24:246-252.
6. Yu H.P., Zhang X.Y., Wang X.L., Shi L.Y., Li Y.Y., Li F., Su Y.H., Wang Y.J., Lu B., Sun X., Lu W.H., Xu S.Q. DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk. Cancer Detect. Prev. 2004, 28:194-199.
7. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1513-1530.
8. Caldecott K.W., McKeown C.K., Tucker J.D., Ljungquist S., Thompson L.H. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol. Cell. Biol. 1994, 14:68-76.
9. Caldecott K.W., Tucker J.D., Stanker L.H., Thompson L.H. Characterization of the XRCC1-DNA ligase III complex in vitro and its absence from mutant hamster cells. Nucleic Acids Res. 1995, 23:4836-4843.
10. Kubota Y., Nash R.A., Klungland A., Schar P., Barnes D.E., Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J. 1996, 15:6662-6670.
11. Friedberg E.C. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 2001, 1:22-33.
12. Wood R.D., Mitchell M., Sgouros J., Lindahl T. Human DNA repair genes. Science 2001, 291:1284-1289.
13. Qiao Y.W., Spitz M.R., Shen H.B., Guo Z.Z., Shete S., Hedayati M., Grossman L., Mohrenweiser H., Wei Q.Y. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002, 23:295-299.
14. Spitz M.R., Wu X., Wang Y., Wang L.E., Shete S., Amos C.I., Guo Z., Lei L., Mohrenweiser H., Wei Q. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001, 61:1354-1357.
15. Vodicka P., Stetina R., Polakova V., Tulupova E., Naccarati A., Vodickova L., Kumar R., Hanova M., Pardini B., Slyskova J., Musak L., De Palma G., Soucek P., Hemminki K. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 2007, 28:657-664.
16. Slyskova J., Dusinska M., Kuricova M., Soucek P., Vodickova L., Susova S., Naccarati A., Tulupova E., Vodicka P. Relationship between the capacity to repair 8-oxoguanine, biomarkers of genotoxicity and individual susceptibility in styrene-exposed workers. Mutat. Res. 2007, 634:101-111.
17. Yen C.Y., Liu S.Y., Chen C.H., Tseng H.F., Chuang L.Y., Yang C.H., Lin Y.C., Wen C.H., Chiang W.F., Ho C.H., Chen H.C., Wang S.T., Lin C.W., Chang H.W. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J. Oral Pathol. Med. 2008, 37:271-277.
18. Pachouri S.S, Sobti R.C., Kaur P., Singh J. Contrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population. DNA Cell Biol. 2007, 26:186-191.
19. Srivastava K., Srivastava A., Mittal B. Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India. Cancer 2010, 116:3160-3169.
20. Genetic landscape of the people of India: a canvas for disease gene exploration. J. Genet. 2008, 87:3-20. Indian Genome Variation Consortium.
21. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 2004, 96:434-442.
22. Dan S., Colla P. CART: Tree-Structured Non-Parametric Data Analysis 1995, Salford Systems, San Diego, CA.
23. Leo B., Friedman J.H., Olshen R., Stone C. Classification and Regression Trees 1984, Wadsworth Inc.
24. Gangwar R., Manchanda P.K., Mittal R.D. Implications of XRCC1, XPD and APE1 gene polymorphism in north Indian population: a comparative approach in different ethnic groups worldwide. Genetica 2009, 136:163-169.
25. Kiran M., Saxena R., Kaur J. Distribution of XRCC1 genotypes in north Indian population. Indian J. Med. Res. 2010, 131:71-75.
26. Sobti R.C., Singh J., Kaur P., Pachouri S.S., Siddiqui E.A., Bindra H.S. XRCC1 codon 399 and ERCC2 codon 751 polymorphism, smoking, and drinking and risk of esophageal squamous cell carcinoma in a north Indian population. Cancer Genet. Cytogenet. 2007, 175:91-97.
27. Mitra A.K., Singh N., Garg V.K., Chaturvedi R., Sharma M., Rath S.K. Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to squamous cell carcinomas of the head and neck (SCCHN) and Breast cancer in the north Indian population. J. Exp. Clin. Cancer Res. 2009, 28:104.
28. Ruwali M., Khan A.J., Shah P.P., Singh A.P., Pant M.C., Parmar D. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors. Environ. Mol. Mutagen. 2009, 50:473-482.
29. Ramachandran S., Ramadas K., Hariharan R., Kumar R.R., Pillai M.R. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol. 2006, 42:350-362.
30. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell. Biol. 1998, 18:3563-3571.
31. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., Bell D.A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999, 59:2557-2561.
32. Duell E.J., Wiencke J.K., Cheng T.J., Varkonyi A., Zuo Z.F., Ashok T.D.S., Mark E.J., Wain J.C., Christiani D.C., Kelsey K.T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000, 21:965-971.
33. Hu J.J., Smith T.R., Miller M.S., Mohrenweiser H.W., Golden A., Case L.D. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 2001, 22:917-922.
34. Abdel-Rahman S.Z., El-Zein R.A. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett. 2000, 159:63-71.
35. Wang Y., Spitz M.R., Zhu Y., Dong Q., Shete S., Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst.) 2003, 2:901-908.
36. Mitra A.K., Singh N., Singh A., Garg V.K., Agarwal A., Sharma M., Chaturvedi R., Rath S.K. Association of polymorphisms in base excision repair genes with the risk of breast cancer: a case-control study in north Indian women. Oncol. Res. 2008, 17:127-135.
37. Mandal R.K., Gangwar R., Mandhani A., Mittal R.D. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from north India. DNA Cell. Biol. 2010, 29:183-190.
38. Kiran M., Saxena R., Chawla Y.K., Kaur J. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol. Cell. Biochem. 2009, 327:7-13.
39. Mittal R.D., Singh R., Manchanda P.K., Ahirwar D., Gangwar R., Kesarwani P., Mandhani A. XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. Cancer Biol. Ther. 2008, 7:645-650.
40. Yuan T., Deng S., Chen M., Chen W., Lu W., Huang H., Xia J. Association of DNA repair gene XRCC1 and XPD polymorphisms with genetic susceptibility to gastric cancer in a Chinese population. Cancer Epidemiol. 2010, 170-174.
41. Sterpone S., Mastellone V., Padua L., Novelli F., Patrono C., Cornetta T., Giammarino D., Donato V., Testa A., Cozzi R. Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J. Cancer Res. Clin. Oncol. 2010, 136:631-636.
42. Kowalski M., Przybylowska K., Rusin P., Olszewski J., Morawiec-Sztandera A., Bielecka-Kowalska A., Pietruszewska W., Mlynarski W., Janusz S., Majsterek I. Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J. Exp. Clin. Cancer Res. 2009, 28:37.
43. Csejtei A., Tibold A., Koltai K., Varga Z., Szanyi I., Gobel G., Prantner I., Steffler D., Feher G., De Blasio A., Ember I., Kiss I. Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population. Anticancer Res. 2009, 29:4169-4173.
44. Ho T., Li G., Lu J., Zhao C., Wei Q., Sturgis E.M. X-ray repair cross-complementing group 1 (XRCC1) single-nucleotide polymorphisms of salivary gland carcinomas. 109th Annual Meeting of the Triological-Society 2006, 318-325.
45. Demokan S., Demir D., Suoglu Y., Kiyak E., Akar U., Dalay N. Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer. Pathol. Oncol. Res. 2005, 11:22-25.
46. Sabitha K., Vishnuvardhan Reddy M., Kaiser Jamil Mutations in XRCC1 gene alters the genetic risks of head and neck cancer patients. Int. J. Cancer Res. 2009, 5:58-68.
47. Kiran M., Chawla Y.K., Jain M., Kaur J. Haplotypes of microsomal epoxide hydrolase and x-ray cross-complementing group 1 genes in Indian hepatocellular carcinoma patients. DNA Cell Biol. 2009, 28:573-577.
48. Langsenlehner T., Renner W., Gerger A., Hofmann G., Thurner E.M., Kapp K.S., Langsenlehner U. Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients. Radiother. Oncol. 2011, 98:387-393.
49. Gangwar R., Ahirwar D., Mandhani A., Mittal R.D. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the north Indian population?. Mutat. Res. 2009, 680:56-63.
50. Srivastava A., Srivastava K., Pandey S.N., Choudhuri G., Mittal B. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in north Indian population. Ann. Surg. Oncol. 2009, 16:1695-1703.
51. Ramachandran S., Ramadas K., Hariharan R., Rejnish Kumar R., Radhakrishna Pillai M. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol. 2006, 42:350-362.
52. Harth V., Schafer M., Abel J., Maintz L., Neuhaus T., Besuden M., Primke R., Wilkesmann A., Thier R., Vetter H., Ko Y.D., Bruning T., Bolt H.M., Ickstadt K. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J. Toxicol. Environ. Health Part A: Curr. Issues 2008, 71:887-897.
53. Tse D., Zhai R.H., Zhou W., Heist R., Asomaning K., Su L., Lynch T., Wain J., Christiani D., Liu G. Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control 2008, 19:1077-1083.
54. Gao W., Romkes M., Zhong S., Nukui T., Persad R.A., Smith P.J., Branch R., Keohavong P. Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. Oncol. Rep. 2010, 24:257-262.
55. Li Y.C., Gu S.H., Wu Q.H., Li Y., Fu X.P., Mao Y.M., Huang Y., Xie Y. No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis. Eur. J. Hum. Genet. 2007, 15:967-973.
56. Coin F., Bergmann E., Tremeau-Bravard A., Egly J.M. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH. EMBO J. 1999, 18:1357-1366.
57. Coin F., Marinoni J.C., Egly J.M. Mutations in XPD helicase prevent its interaction and regulation by p44, another subunit of TFIIH, resulting in xeroderma pigmentosum (XP) and trichothiodystrophy (TTD) phenotypes. Pathol. Biol. (Paris) 1998, 46:679-680.
58. Sreeja L., Syamala V.S., Syamala V., Hariharan S., Raveendran P.B., Vijayalekshmi R.V., Madhavan J., Ankathil R. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J. Cancer Res. Clin. Oncol. 2008, 134:645-652.
59. Casson A.G., Zheng Z., Evans S.C., Veugelers P.J., Porter G.A., Guernsey D.L. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 2005, 26:1536-1541.
60. Weiss J.M., Weiss N.S., Ulrich C.M., Doherty J.A., Chen C. Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association. Gynecol. Oncol. 2006, 103:891-896.
61. Boffetta P., Hashibe M. Alcohol and cancer. Lancet Oncol. 2006, 7:149-156.
62. Yadav B.K., Kaur J., Srivastava A., Ralhan R. Effect of polymorphisms in XRCC1, CCND1 and GSTM1 and tobacco exposure as risk modifier for oral leukoplakia. Int. J. Biol. Markers 2009, 24:90-98.
63. Sturgis E.M., Zheng R., Li L., Castillo E.J., Eicher S.A., Chen M.H., Strom S.S., Spitz M.R., Wei Q.Y. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 2000, 21:2219-2223.
64. Ma H., Hu Z., Zhai X., Wang S., Wang X., Qin J., Chen W., Jin G., Liu J., Gao J., Wei Q., Shen H. Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population. Carcinogenesis 2006, 27:766-771.